Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Blossomhill Therapeutics(BLSM) the EBIT is -22.11 M (-93.01%);the EPS is -8.14 (-85.45%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.02B93.01%
----
----
EPS
-8.142385.45%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf